Beta Bionics, Inc. (NASDAQ: BBNX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BETA BIONICS, INC.

Beta Bionics, Inc. (NASDAQ: BBNX)
Listen to this Section


$17.57
-0.2500 ( -1.40% ) 798.5K

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Market Data


Open $17.57
Previous Close $17.82
Volume 798.5K
Market Cap $794.09M
Day Range $17.03 - $18.24
52 Week Range $8.80 - $32.71
Shares Outstanding 44.56M
Change % -1.40%
Net Change ▼ -0.2500
Insider Ownership N/A
Exchange NASDAQ
SectorIndustrials
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
IPO Year2025
CountryUnited States
UnderwriterBofA Securities, Piper Sandler, Leerink Partners, Stifel, Lake Street Capital Markets, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 05, 2025
4 Insider transactions 1 Nov 05, 2025
8-k 8K-related 14 Oct 28, 2025
10-q Quarterly Reports 91 Oct 28, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Oct 03, 2025
4 Insider transactions 1 Sep 09, 2025
4 Insider transactions 1 Sep 08, 2025
4 Insider transactions 1 Sep 08, 2025
4 Insider transactions 1 Sep 04, 2025

Latest News